168 related articles for article (PubMed ID: 19451400)
1. Identification of new 2-amino-3-methylimidazo[4,5-f]quinoline urinary metabolites from beta-naphthoflavone-treated mice.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2009 Aug; 37(8):1690-7. PubMed ID: 19451400
[TBL] [Abstract][Full Text] [Related]
2. N-Demethylation is a major route of 2-amino-3-methylimidazo[4,5-f]quinoline metabolism in mouse.
Lakshmi VM; Hsu FF; Zenser TV
Drug Metab Dispos; 2008 Jun; 36(6):1143-52. PubMed ID: 18356269
[TBL] [Abstract][Full Text] [Related]
3. Characterization of new metabolites from in vivo biotransformation of 2-amino-3-methylimidazo[4,5-f]quinoline in mouse by mass spectrometry.
Hsu FF; Lakshmi VM; Zenser TV
J Mass Spectrom; 2009 Sep; 44(9):1359-68. PubMed ID: 19629964
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of a heterocyclic amine colon carcinogen in young and old rats.
Armbrecht HJ; Lakshmi VM; Wickstra J; Hsu FF; Zenser TV
Drug Metab Dispos; 2007 Apr; 35(4):633-9. PubMed ID: 17251306
[TBL] [Abstract][Full Text] [Related]
5. Urinary excretion of N-OH-2-amino-3-methylimidazo[4,5-f]quinoline-N-glucuronide in F344 rats is enhanced by green tea.
Embola CW; Weisburger JH; Weisburger MC
Carcinogenesis; 2001 Jul; 22(7):1095-8. PubMed ID: 11408354
[TBL] [Abstract][Full Text] [Related]
6. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen peroxide supports human and rat cytochrome P450 1A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase.
Anari MR; Josephy PD; Henry T; O'Brien PJ
Chem Res Toxicol; 1997 May; 10(5):582-8. PubMed ID: 9168257
[TBL] [Abstract][Full Text] [Related]
9. The disposition and metabolism of 2-amino-3-methylimidazo-[4,5-f]quinoline in the F344 rat at high versus low doses of indole-3-carbinol.
Dashwood RH; Xu M
Food Chem Toxicol; 2003 Aug; 41(8):1185-92. PubMed ID: 12842187
[TBL] [Abstract][Full Text] [Related]
10. Protection by green tea, black tea, and indole-3-carbinol against 2-amino-3-methylimidazo[4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat.
Xu M; Bailey AC; Hernaez JF; Taoka CR; Schut HA; Dashwood RH
Carcinogenesis; 1996 Jul; 17(7):1429-34. PubMed ID: 8706244
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay.
Snyderwine EG; Welti DH; Fay LB; Würzner HP; Turesky RJ
Chem Res Toxicol; 1992; 5(6):843-51. PubMed ID: 1489936
[TBL] [Abstract][Full Text] [Related]
12. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans.
Malfatti MA; Kulp KS; Knize MG; Davis C; Massengill JP; Williams S; Nowell S; MacLeod S; Dingley KH; Turteltaub KW; Lang NP; Felton JS
Carcinogenesis; 1999 Apr; 20(4):705-13. PubMed ID: 10223203
[TBL] [Abstract][Full Text] [Related]
13. Green tea and the metabolism of 2-amino-3-methylimidazo.
Embola CW; Weisburger MC; Weisburger JH
Food Chem Toxicol; 2001 Jun; 39(6):629-33. PubMed ID: 11346494
[TBL] [Abstract][Full Text] [Related]
14. Prenylflavonoids from hops inhibit the metabolic activation of the carcinogenic heterocyclic amine 2-amino-3-methylimidazo[4, 5-f]quinoline, mediated by cDNA-expressed human CYP1A2.
Miranda CL; Yang YH; Henderson MC; Stevens JF; Santana-Rios G; Deinzer ML; Buhler DR
Drug Metab Dispos; 2000 Nov; 28(11):1297-302. PubMed ID: 11038156
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline formed after incubation with isolated rat liver cells.
Alexander J; Holme JA; Wallin H; Becher G
Chem Biol Interact; 1989; 72(1-2):125-42. PubMed ID: 2510946
[TBL] [Abstract][Full Text] [Related]
16. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
Edenharder R; Rauscher R; Platt KL
Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of 2-amino-3-methylimidazo[4,5-f]quinoline in the male rat.
Inamasu T; Luks H; Vavrek MT; Weisburger JH
Food Chem Toxicol; 1989 Jun; 27(6):369-76. PubMed ID: 2792966
[TBL] [Abstract][Full Text] [Related]
18. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
19. Identification of sulfate and glucuronic acid conjugates of the 5-hydroxy derivative as major metabolites of 2-amino-3-methylimidazo[4,5-f]quinoline in rats.
Luks HJ; Spratt TE; Vavrek MT; Roland SF; Weisburger JH
Cancer Res; 1989 Aug; 49(16):4407-11. PubMed ID: 2743329
[TBL] [Abstract][Full Text] [Related]
20. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
